Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Código QR

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Stefan Nierkens, Niels Eijkelkamp, Maaike Nederend, Jeanette Leusen, Mitchell Evers, Marjolein Stip, Kaylee Keller, Hanneke Willemen, Marco Jansen, Chilam Chan, Kevin Budding, Thomas Valerius, Friederike Meyer-Wentrup
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/22ca94048a6c4dd2acf901975662eb6e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
por: Babak Moghimi, et al.
Publicado: (2021)

Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
por: Nicola Tumino, et al.
Publicado: (2021)

A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy
por: Zhang L, et al.
Publicado: (2021)

Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
por: C. Rääf, et al.
Publicado: (2020)

Neuroblastoma
por: Fuentes,Luis, et al.
Publicado: (1976)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Salama Hegazy, et al.
Publicado: (2016)

Deficiencia de IgA
por: SORENSEN D,RICARDO
Publicado: (1973)

PARATESTICULAR INVOLVEMENT IN NEUROBLASTOMA
por: Volkan KÖSE, et al.
Publicado: (2021)

NEPHRITOGENIC ACTIVITY OF IgA-BINDING STREPTOCOCCUS PYOGENES: AN EXPERIMENTAL MODEL OF IgA GLOMERULONEPHRITIS
por: L. A. Burova, et al.
Publicado: (2016)

Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.
por: Marjolein van Waas, et al.
Publicado: (2012)

Estesioneuroblastoma o neuroblastoma olfatorio
por: Benet M,Sergio, et al.
Publicado: (2017)

Neuroblastomas en el niño
por: E,BAUZA, et al.
Publicado: (1950)

Neuroblastoma en la infancia
por: del Pozo,H, et al.
Publicado: (1976)

Neuroblastoma in an adult: Case report
por: MIRANDA SOARES,PRISCILA BERNARDINA, et al.
Publicado: (2010)

IgA Nephropathy Secondary to Ipilimumab Use
por: Sean C. Dougherty, et al.
Publicado: (2021)

IMMUNOGLOBULIN A (IgA) AND ITS RECEPTORS
por: V. B. Klimovich, et al.
Publicado: (2014)

Deficiencia de IgA: análisis clínico
por: Lamas S,Roger, et al.
Publicado: (1976)

IgA nephropathy: A Chinese perspective
por: Zhao Zhang, et al.
Publicado: (2021)

A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.
por: Nidia Alvarez-Rueda, et al.
Publicado: (2011)

Role of Energy Metabolism in the Progression of Neuroblastoma
por: Monika Sakowicz-Burkiewicz, et al.
Publicado: (2021)

Kill Your Darlings

EDITORIAL: Killing the messenger
por: David Robie
Publicado: (2018)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Ramona Erber, et al.
Publicado: (2021)

Crown Ether-Immobilized Cellulose Acetate Membranes for the Retention of Gd (III)
por: Oana Steluta Serbanescu, et al.
Publicado: (2021)

Cross-beta nanostructures based on dinaphthylalanine Gd-conjugates loaded with doxorubicin
por: Carlo Diaferia, et al.
Publicado: (2017)

Hydroxychloroquine in IgA nephropathy: a systematic review
por: Gabriel Stefan, et al.
Publicado: (2021)

Deficiencia selectiva de inmunoglobulina A (IgA)
por: King D,Alexandra, et al.
Publicado: (1992)

Pathogenesis of IgA Vasculitis: An Up-To-Date Review
por: Yan Song, et al.
Publicado: (2021)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Maged Zeineldin, et al.
Publicado: (2020)

Integrative discovery of treatments for high-risk neuroblastoma
por: Elin Almstedt, et al.
Publicado: (2020)

Identification of novel neuroblastoma biomarkers in urine samples
por: Kazuki Yokota, et al.
Publicado: (2021)

Restoration of the molecular clock is tumor suppressive in neuroblastoma
por: Myrthala Moreno-Smith, et al.
Publicado: (2021)

Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman WL
Publicado: (2021)

Neuroblastoma intrarenal mimetizando tumor de Wilms
por: Maria T. Cartaxo Muniz, et al.
Publicado: (2005)

Olfactory neuroblastoma managed with endoscopic sinus surgery
por: Saleh Mayoof Al-Osaimi, et al.
Publicado: (2021)

NEUROBLASTOMA IN A CASE OF CONGENITAL ADRENAL HYPERPLASIA
por: Arzu Yazal Erdem, et al.
Publicado: (2021)

Layer-selective magnetization switching in the chirped photonic crystal with GdFeCo
por: O. V. Borovkova, et al.
Publicado: (2021)

DTPAA-Gd Functionalized Ultrasmall Au15NCs Nanohybrids for Multimodal Imaging
por: Wu M, et al.
Publicado: (2020)

Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement
por: Hedlund A, et al.
Publicado: (2011)

ORDERED L-FUZZY Gd-EXTREMALLY DISCONNECTED SPACES AND TIETZE EXTENSION THEOREM
por: ROJA,E, et al.
Publicado: (2008)